“…However, such patients represent a large portion of those with unruptured AVMs in the community, thereby compromising the generalisability of the study's findings. Furthermore, as the different AVM treatment modalities have progressed considerably during the last two decades [5,8,11,21,23], the threshold for proposing a prophylactic treatment of AVMs considered to harbour a high risk of rupture has been lowered, despite the results of different studies regarding the rupture risk factors [4,6,8,9,20]. Consequently, the patients included in ARUBA had possibly low-risk AVMs with a more favourable natural history.…”